Full data view for gene TSC1

The curator’s expert opinion on the classification of a variant, can be found in the
SUMMARY record. Regarding the classification, please note that where there are several
records of the same variant, the classification of that variant may differ depending on the
submitter’s conclusion.
Information The variants shown are described using the NM_000368.4 transcript reference sequence.

7 entries on 1 page. Showing entries 1 - 7.
Legend   How to query  

Effect     

Exon     

AscendingDNA change (cDNA)     

RNA change     

Protein     

P-domain     

Predict-BioInf     

Allele     

Classification method     

Clinical classification     

DNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Template     

Technique     

Tissue     

Remarks     

Disease     

ID_report     

Reference     

Remarks     

Gender     

Consanguinity     

Country     

Population     

Age at death     

VIP     

Data_av     

Treatment     

Panel size     

Owner     
+/. 4 c.163C>T - p.Gln55* - - Unknown - NA g.135802635G>A g.132927248G>A - - TSC1_000311 complete absence of TSC1 expression seen in the cell line HCV29 PubMed: Hoogeveen-Westerveld, 2011 - - In vitro (cloned) - - - - - - - - - - - - - - - - - - - - - - -
+/. 4 c.163C>T r.(?) p.(Gln55*) - - Unknown - pathogenic (dominant) g.135802635G>A g.132927248G>A 384C>T - TSC1_000311 homozygous variant in bladder tumour-derived cell line (transitional cell carcinoma); possibility of being germline mutation not excluded as non-tumour DNA unavailable PubMed: van Tilborg, 2001; PubMed: Knowles, 2003; PubMed: Knowles, 2003; PubMed: Guo, 2013 - - Somatic - - BspCNI- - - DNA HD, SSCA, SSCAf Bladder tumour cell line - cancer, bladder - PubMed: van Tilborg, 2001; PubMed: Knowles, 2003; PubMed: Knowles, 2003; PubMed: Guo, 2013 no TSC features in patient; same transitional cell carcinoma cell line reported in all papers ? - - - - - - - 1 Rosemary Ekong
+/. 4 c.163C>T r.(?) p.(Gln55*) - - Unknown - pathogenic (dominant) g.135802635G>A g.132927248G>A - - TSC1_000311 found with TSC1 missense c.1001C>T unpublished - - De novo - 1/3 individuals tested have the variant BspCNI- - - DNA SEQ Blood - TSC - unpublished 1 affected in 1 generation; proband has a de novo TSC1 nonsense variant c.163C>T and TSC1 missense c.1001C>T; TSC1 nonsense c.163C>T absent in both parents, but TSC1 missense c.1001C>T present in one healthy parent ? - - - - - - - 1 Rosemary Ekong
+/. 4 c.163C>T r.(?) p.(Gln55*) - - Unknown - pathogenic (dominant) g.135802635G>A g.132927248G>A - - TSC1_000311 variant seen in cohort of 96 high-grade bladder cancers PubMed: Iyer, 2013 - - Somatic - - BspCNI- - - DNA SEQ Bladder tumour - cancer, bladder - PubMed: Iyer, 2013 - ? - - - - - - - 1 Rosemary Ekong
+/. 4 c.163C>T r.(?) p.(Gln55*) - - Unknown - pathogenic (dominant) g.135802635G>A g.132927248G>A c.384C>T, p.Q55X - TSC1_000311 variant seen in bladder tumour from a patient PubMed: Guo, 2013 - - Somatic - - BspCNI- - - DNA SEQ Bladder tumour - cancer, bladder - PubMed: Guo, 2013 variant in bladder tumour from patient ? - - - - - - - 1 Rosemary Ekong
+/. 4 c.163C>T r.(?) p.(Gln55*) - - Unknown - pathogenic (dominant) g.135802635G>A g.132927248G>A - - TSC1_000311 variant seen in bladder tumour from a patient unpublished - - Somatic - 2/4 individuals tested have the variant BspCNI- - - DNA DHPLC, SEQ Blood - TSC - unpublished a sibling has the same variant; both parents tested negative; germline mosaicism in one of the parents cannot be excluded F - - - - - - - 2 Rosemary Ekong
+/+ 4 c.163C>T r.(?) p.(Gln55*) - - Unknown - pathogenic (dominant) g.135802635G>A g.132927248G>A - - TSC1_000311 - - - - SUMMARY record - - - - - - - - - - - - - - - - - - - - - - -
Legend   How to query  

Assessment of functional consequences - Our conclusions on the functional consequences of variants are based on the type of variant, results of in vitro functional tests (doi: 10.1002/humu.21451; doi: 10.1002/humu.22202; doi: 10.1002/humu.23963), population frequencies, output from in silico splice site prediction algorithms, and any clinical/family data available to us. We also have output from protein prediction programs in this database for comparison purposes and they are not considered in our assessment of pathogenicity. PolyPhen Predictions - Note that these results are from PolyPhen-2 and only the HumDiv classification is shown.


Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.